These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19622971)

  • 61. Dyspareunia in Women.
    Hill DA; Taylor CA
    Am Fam Physician; 2021 May; 103(10):597-604. PubMed ID: 33983001
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Botulinum toxin and intractable trigeminal neuralgia.
    Türk U; Ilhan S; Alp R; Sur H
    Clin Neuropharmacol; 2005; 28(4):161-2. PubMed ID: 16062093
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Botulinum toxin A and lower urinary tract symptoms: non multa, sed multum (not many, but much).
    Lazzeri M
    Eur Urol; 2009 Jan; 55(1):59-61. PubMed ID: 18835657
    [No Abstract]   [Full Text] [Related]  

  • 64. Pelvic pain: a diagnosis in itself.
    Garad R; Vancaillie TG; Farrell E
    Aust Nurs Midwifery J; 2013 Sep; 21(3):36-9. PubMed ID: 24279095
    [No Abstract]   [Full Text] [Related]  

  • 65. Botulinum Toxin for the Management of Sjögren Syndrome-Associated Recurrent Parotitis.
    O'Neil LM; Palme CE; Riffat F; Mahant N
    J Oral Maxillofac Surg; 2016 Dec; 74(12):2428-2430. PubMed ID: 27400144
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gynecological indications for the use of botulinum toxin in women with chronic pelvic pain.
    Abbott J
    Toxicon; 2009 Oct; 54(5):647-53. PubMed ID: 19264089
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of Dyspareunia with Botulinum Neurotoxin Type A: Clinical Improvement and Influence of Patients' Characteristics.
    Tarazona-Motes M; Albaladejo-Belmonte M; Nohales-Alfonso FJ; De-Arriba M; Garcia-Casado J; Alberola-Rubio J
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444532
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Posterior pelvic floor prolapse and a review of the anatomy, preoperative testing and surgical management.
    Kleeman SD; Karram M
    Minerva Ginecol; 2008 Apr; 60(2):165-82. PubMed ID: 18487967
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effectiveness, Safety, and Predictors of Response to Botulinum Toxin Type A in Refractory Masticatory Myalgia: A Retrospective Study.
    Khawaja SN; Scrivani SJ; Holland N; Keith DA
    J Oral Maxillofac Surg; 2017 Nov; 75(11):2307-2315. PubMed ID: 29078865
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Botulinum toxin a for vulvodynia: a case report.
    Gunter J; Brewer A; Tawfik O
    J Pain; 2004 May; 5(4):238-40. PubMed ID: 15162347
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Excellent response rate of anismus to botulinum toxin if rectal prolapse misdiagnosed as anismus ('pseudoanismus') is excluded.
    Hompes R; Harmston C; Wijffels N; Jones OM; Cunningham C; Lindsey I
    Colorectal Dis; 2012 Feb; 14(2):224-30. PubMed ID: 21689279
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Botulinum toxin type A for treatment of dyspareunia caused by localized scleroderma.
    Mousty E; Rathat G; Rouleau C; Giacalone PL
    Acta Obstet Gynecol Scand; 2011 Aug; 90(8):926-7. PubMed ID: 21564031
    [No Abstract]   [Full Text] [Related]  

  • 73. [Botulinum toxin for postoperative care after limb surgery in cerebral palsy children].
    Dohin B; Garin C; Vanhems P; Kohler R
    Rev Chir Orthop Reparatrice Appar Mot; 2007 Nov; 93(7):674-81. PubMed ID: 18065878
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Botulinum Toxin Type A Injections as an Effective Treatment of Refractory Multiple Sclerosis-Related Trigeminal Pain - A Case Report.
    Calejo M; Salgado P; Moreira B; Correia C; Barros J
    Headache; 2019 Sep; 59(8):1379-1381. PubMed ID: 31424566
    [No Abstract]   [Full Text] [Related]  

  • 75. Can Fear, Pain, and Muscle Tension Discriminate Vaginismus from Dyspareunia/Provoked Vestibulodynia? Implications for the New DSM-5 Diagnosis of Genito-Pelvic Pain/Penetration Disorder.
    Lahaie MA; Amsel R; Khalifé S; Boyer S; Faaborg-Andersen M; Binik YM
    Arch Sex Behav; 2015 Aug; 44(6):1537-50. PubMed ID: 25398588
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome.
    Wheeler AH; Goolkasian P; Gretz SS
    Spine (Phila Pa 1976); 1998 Aug; 23(15):1662-6; discussion 1667. PubMed ID: 9704373
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
    Zúñiga C; Díaz S; Piedimonte F; Micheli F
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):500-3. PubMed ID: 18813708
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Is hysterectomy necessary for laparoscopic pelvic floor repair? A prospective study.
    Rosen DM; Shukla A; Cario GM; Carlton MA; Chou D
    J Minim Invasive Gynecol; 2008; 15(6):729-34. PubMed ID: 18971137
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pelvic floor physical therapy for lifelong vaginismus: a retrospective chart review and interview study.
    Reissing ED; Armstrong HL; Allen C
    J Sex Marital Ther; 2013; 39(4):306-20. PubMed ID: 23470141
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.